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Introduction 
  
ahr's disease is Familial Idiopathic Basal 
Ganglia Calcification characterized by 
bilateral intracranial calcification and 
associated with neuropsychiatric 
manifestations. Fahr's disease referred to 
Fahr's (German neurologist) who described 
a case with bilateral calcifications in the 
basal ganglia and other parts of the brain in 
1930, despite the fact that he was not the 
first to describe this kind of calcification nor 
did he contribute significantly to the 
understanding of this disorder1.  Most cases 
of Fahr's disease are autosomal dominant, 
but familial and sporadic cases had been 
documented and autosomal recessive cases 
had been reported2,3. In dominant cases, 
most of afflicted family members by cerebral 
calcification are asymptomatic and even 
some of them may not show calcification 
changes till they get older. Although there is 
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no strong evidence and some researchers 
doubt it, TULIP1 gene on chromosome 14q 
has been suggested to be the responsible 
gene (For what? Farah's disease?) 4- 7. 
Fahr's disease cases are usually diagnosed 
by exclusion of other causes of Fahr’s 
syndrome e.g. hypoparathyroidism, 
neurobrucellosis, CNS TB, toxoplasmosis, 
Wilson disease and Huntington’s disease. 
 
Case Report 
A 26-year-old single retired soldier, 
schizophrenic patient, admitted to  
psychiatric ward on 2004 after seeing the 
outpatient psychiatric clinics in the Military 
Hospital with his family. The patient’s 
family reported that he started to develop 
abnormal involuntary movement of the 
trunk and upper limbs which worsen 
progressively and interfered with his daily 
live activity during the last six months prior 
to his visit. They also admitted that he had 
low self care, aggressive behavior but 
denied any recent history of thought, 
perception or cognitive abnormalities. 
Actually, the patient was seen in the out-
patient clinics before, where his condition 
was diagnosed as drug induced movement 
disorder -extrapyramidal side effect 
secondary to his antipsychotic medication- 
(Resperidone 4 m.g, Procyclidine 5 m.g and 
Fluanxol depot 30 mg every 4 weeks), 
antipsychotic discontinued and his 
anticholinergic drugs increased without any 
improvement. 
The patient was diagnosed as a case of 
schizophrenia for 4 years after he suddenly 
developed paranoid delusions with 
aggressive behavior. During this period the 
patient  was admitted  three  times in three 
different tertiary hospitals, diagnosed as a 
case of Paranoid schizophrenia, and 
prescribed different kinds of typical and 
atypical antipsychotic medications, but he 
didn't fulfill his medication and his 
condition deteriorated progressively inform 
of positive and negative symptoms' of 
schizophrenia (and he has been retired? 
What does this mean? The patient retired 
because of the negative effect his case had or 
because of him not complying with his 
medication?). 
The patient is the 4th amongst his 10 
siblings, 7 males and 3 females, whom were 
all healthy with no history of psychiatric or 
neurological disorders. His parents denied 
any heredity of similar conditions of 
abnormal movements in the family. 
The examination of the patient's 
neurological and mental state showed a 
calm, cooperative, older than his stated age, 
thin, unclean dressing with poor self  
hygiene patient. 
The patient demonstrated an abnormal 
bizarre choreoathetoid movement of trunk 
and upper limbs, dysartheric speech and 
euthymic mood with appropriate affect and 
his perceptual feeling intact. Upon 
examinations of his thought and cognition 
revealed no abnormalities. Other physical 
examinations were unremarkable. 
Upon the patient's admission at a 
neurologist was consulted and an MRI scan 
and the following investigations were done: 
CBC, U&E, LFT, parathyroid hormone, HIV, 
syphilis, Hepatitis viruses screening& urine 
drug screening. 
All of the patient's lab tests were within 
normal limits and his MRI showed the 
following: Calcific changes, which involved 
basal ganglia bilaterally, both dentate nuclei 
and subcortical area and centrum semiovale 
of both hemispheres (Figure 1). After that, a 
radiologist asked for a CT scan, which 
confirmed the finding and revealed 
extension of calcification to caudate nuclei, 
inferior aspect of thalami and cerebellum 
(Figure 2, 3). 
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Figure 1: MRI Brain demonstrated calcific changes which involved basal ganglia bilaterally. 
 
 
Figure 2: CT Brain revealed calcification of caudate nuclei. 
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Figure 3: CT Brain revealed extension of calcification to cerebellum 
 
 
 
Therefore, the patient's condition was 
diagnosed as Fahr’s Disease after the 
exclusion of other disorders like, Wilson 
disease and metabolic disorder related to 
parathyroid hormone. 
Upon admission to (Where?), the patient 
received a small dose of clozapine, which 
was discontinued, then Tetrabenazine was 
prescribed by neurologist, who added 
Sodium valproate later. The patient's 
condition did not show any marked changes 
and was discharged in order to be admitted 
to a long-term rehabilitation facility. 
However, after that, patient was seen once 
at an ER with the same presentation, but no 
more visits were made since then 
 
Discussion 
 
The most common sites of calcifications are 
basal ganglia and dentate nuclei of 
cerebellum. Hence, one of the other names 
of the disease is Bilateral Striopallidodentate 
Calcification (BSPDC). However, 
calcification can involve centrum ovale. 
Thalami, cerebral cortex, subcortex and no 
part of the brain could be spared. The 
extension of calcification is directly related 
to the psychiatric manifestations, but not to 
the neurological ones, which could explain 
the presentation of the acute psychosis in 
the patient in this study8. Functional brain 
neuroimaging showed different inconsistent 
findings according to the clinical 
presentation, showing part of the brain 
affected by calcification9- 11. 
Postmortem histology studies of the lesions 
showed mainly calcium compositions, but 
other items like phosphorus, iron, 
magnesium, aluminum and zinc had been 
identified as well. However, no important 
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clinical issues were related to these 
components 12,13. 
Fahr's disease has a broad spectrum of 
clinical neurological presentation. Patients 
can be presented with movement disorders, 
executive and cognitive impairment, 
seizures, pain, pyramidal symptoms, 
cerebellar signs and other different 
presentation, depending on which part of 
the brain was affected by lesion1,14. Manyam 
BV et al. 2001 analyzed presentations of 
sixty one symptomatic cases and found that 
movement disorders were the most common 
presentation, which accounted for 55% of 
clinical presentations Parkinsonism 57%, 
chorea 19%, tremor 8%, dystonia 8%, 
athetosis 5% and orofacial dyskinesia 3% 15. 
About 40% of patients with Fahr's disease 
present initially with psychiatric features16. 
Cognitive, psychotic, and mood disorders 
are the most common presentations. Fahr's 
disease may present as a progressive 
subcortical dementia in elder patients and 
those who were presented earlier with other 
psychiatric presentations e.g. psychosis, 
mood disturbance, are most likely to 
progress to dementia17,27. Paranoid and 
psychotic features occur between the ages of 
20 and 40. They may take the form of 
delusions, persecutory ideas, auditory and 
visual hallucinations or fugue state17-21. 
Mood disturbances are the most frequent 
psychiatric presentations and eventually 
afflict two-thirds of the patients and up to 
one-third may be affected by anxiety 
disorders16,22. Fahr's disease has poor 
prognosis since there is not an effective 
calcium chelating agent or another modality, 
which could affect intracranial calcification 
masses. Neuropsychiatric complications of 
the illness had different responses to 
antiparkinsontic and antipsychotic 
medications, though markedly less 
improvements than those seen with genuine 
diagnoses23-25.  In mood disorders, 
antidepressant agents showed good 
responses26.  
In the case presented in this study, it is not 
clear if the past active psychotic episodes of 
the patient were a genuine schizophrenic 
manifestation (supported by typical age at 
presentation and progressive course of the 
illness over long period) or just an early 
psychiatric presentation of  Fahr's disease 
that preceded the movement disorder. Since 
the presentation is sudden, no family history 
of schizophrenia and because of the 
extensive calcification that was most likely 
to be there at the start of psychosis, the 
researchers suggest the later diagnosis, 
starting psychotic patients on antipsychotic 
need close monitoring and observation for 
any side effect development like movement 
abnormalities especially if there is no 
response to anticholinergic medications. 
Cerebral imaging is strongly indicated when 
patients without a family history of 
psychosis are presented with sudden 
psychosis or a case of unordinary movement 
complication to antipsychotic medication 
not responding to the usual interventions. 
Professionals in the psychiatric field should 
be more educated about other differentials 
and causes of medications' side effects in 
advance. 
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